Strengthening the global diagnostic capacity in the battle against Corona Virus

The Corona Virus Disease-2019 (COVID-19) pandemic has taken the world by storm and since its emergence in the Wuhan city of China, the number of confirmed cases has been ever-rising. There is an immense need for the national leaders to prioritize COVID-19 and take targeted measures to improve diagnostic, case surveillance, infection prevention & control, treatment, risk communication and community engagement activities. From the diagnostic perspective, a significant improvement needs to be done as the dynamics of the outbreak is changing with each day. It has been envisaged that each of the nations should strengthen their capacity to detect the virus and not be dependent on other nations for the same as this will unnecessarily delay the diagnosis. In conclusion, amidst the reports of a rise in the number of asymptomatic cases and in the global battle against the COVID-19 outbreak, there is an indispensable need to strengthen serological testing and simultaneously improve the diagnostic capacity of the laboratories to ensure a better response against the disease.

___

1. World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report – 180; 2020. Available from: https://www.who.int/ docs/default-source/coronaviruse/situation-reports/20200718-covid-19- sitrep-180.pdf?sfvrsn=39b31718_2 [Last accessed on 2020 Jul 19].

2. Jernigan DB; CDC COVID-19 response team. Update: Public health response to the Coronavirus disease 2019 outbreak - United States, February 24, 2020. MMWRMorb Mortal Wkly Rep. 2020;69:216-9.

3. World Health Organization. 2019 Novel Coronavirus (2019-nCoV): Strategic preparedness and response plan. Geneva: WHO press; 2020. p: 1-20.

4. World Health Organization. Laboratory biosafety guidance related to coronavirus disease 2019 (COVID-19) - Interim guidance. Geneva: WHO press; 2020. p:1-4.
Medicine Science-Cover
  • ISSN: 2147-0634
  • Yayın Aralığı: Yılda 4 Sayı
  • Başlangıç: 2012
  • Yayıncı: Effect Publishing Agency ( EPA )
Sayıdaki Diğer Makaleler

Nivolumab in relapsed/refractory Hodgkin Lymphoma patients, single center experiences

Ramazan ACAR, Murat YILDIRIM

Evaluation of home accidents of forensic nature among children

Nusret AYAZ, Kasım TURGUT, Muhammet Gökhan TURTAY, Taner GÜVEN, Mücahit ORUÇ, Osman CELBİŞ

Vitamin D: An effective way to combat methotrexate-induced testis injury

Alper YALÇIN, Hasan AYDIN, Ahmet TÜRK, Mevlüt DOĞUKAN, Nadire ESER, Muhittin ÖNDERCİ, Fatih ÜÇKARDEŞ, Atila YOLDAS, Erkan YILMAZ, Hikmet KELEŞ

Evaluation of manganese superoxide dismutase and thioredoxin2 levels in asbestos-induced pleural mesothelioma

Abdullah SİVRİKAYA, Bayram METİN, Esma MENEVSE, Yavuz Selim İNTEPE, Ayşe Yeşim GÖÇMEN

Investigation of the effect on prostate cancer purine base analog of the newly developed compound

Gökhan TEMELTAŞ, Funda KOSAVA, Özlem TEMİZ ARPACI, İbrahim TUĞLU

Morphometric anatomic study and clinical significance of the collateral ligaments of the thumb interphalangeal joint

Merve ÖNDER, Cengiz ALDEMİR

Ectopic omental deciduosis associated with pregnancy

Elif ÇETİN, Mumine GÖRMEZ, Akgül ARICI, Reşit Doğan KÖSEOĞLU

Approach of ACLS for stroke patients

Adel Hamed ELBAIH, Mahmoud DIBAS

The value of routine blood test parameters obtained at admission to predict acute stent thrombosis in patients with st-segment elevation myocardial infarction

Yusuf ÇEKİCİ

Factors associated with seizure recurrence after antiepileptic drug withdrawal

Aslı Ece ÇİLLİLER, Bülent GÜVEN